RED RAVEN LIMITED
Company number 07153952 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Assessment: RED RAVEN LIMITED
1. Financial Health Score: D+
Explanation: Red Raven Limited presents the financial profile of a company in chronic decline. While the patient is not in immediate critical condition—liabilities are negligible and the company remains solvent—the vital signs reveal a persistent and worsening hemorrhage of shareholder value. Net assets have deteriorated by approximately 87% over the past decade, and at the current rate of cash depletion, the company faces serious sustainability concerns within 12-18 months without intervention.
2. Key Vital Signs
Net Assets Trend (The "Blood Pressure" Reading)
| Year | Net Assets | Year-on-Year Change |
|---|---|---|
| 2017 | £709,719 | — |
| 2018 | £697,960 | -£11,759 |
| 2019 | £531,316 | -£166,644 |
| 2020 | £488,849 | -£42,467 |
| 2021 | £483,563 | -£5,286 |
| 2022 | £432,297 | -£51,266 |
| 2023 | £359,057 | -£73,240 |
| 2024 | £274,827 | -£84,230 |
| 2025 | £179,951 | -£94,876 |
| 2026 | £93,314 | -£86,637 |
Interpretation: This is the financial equivalent of steadily dropping blood pressure. The company has lost over £616,000 in net assets over nine years, with annual losses accelerating from around £12,000 in 2018 to nearly £95,000 in 2025. The condition is chronic and worsening.
Cash Position (The "Heart Rate")
| Year | Cash | Year-on-Year Change |
|---|---|---|
| 2017 | £342,300 | — |
| 2018 | £323,846 | -£18,454 |
| 2019 | £156,412 | -£167,434 |
| 2020 | £114,663 | -£41,749 |
| 2021 | £107,568 | -£7,095 |
| 2022 | £56,731 | -£50,837 |
| 2023 | £358,536 | +£301,805 |
| 2024 | £274,934 | -£83,602 |
| 2025 | £179,773 | -£95,161 |
| 2026 | £93,592 | -£86,181 |
Interpretation: Cash is the lifeblood of any business, and Red Raven's is draining away at an alarming rate. The anomalous spike in 2023 (from £56,731 to £358,536) suggests a one-off injection—likely the sale of investments or other assets previously held—rather than improved trading performance. The subsequent resumption of heavy cash burn confirms this was not a sustainable recovery.
Current cash burn rate: Approximately £86,000-£95,000 per year.
Estimated cash runway: At the current rate, approximately 12-13 months before cash is fully depleted.
Current Ratio (The "Immune System" Strength)
| Year | Current Assets | Current Liabilities | Current Ratio |
|---|---|---|---|
| 2025 | £181,127 | £919 | 197:1 |
| 2026 | £94,495 | £1,010 | 93:1 |
Interpretation: An extraordinarily strong current ratio—effectively meaning the company can meet its short-term obligations many times over. However, this is misleading; the ratio is high only because liabilities are virtually non-existent. The company has minimal trade creditors and no debt, which also means it is not leveraging external financing to support operations.
Liabilities (The "Cholesterol" Check)
| Year | Total Liabilities |
|---|---|
| 2025 | £919 |
| 2026 | £1,010 |
Interpretation: Negligible liabilities are the one genuinely healthy sign. The company has no external debt, minimal trade creditors, and only a small deferred tax provision (£171). This means no creditor pressure and no risk of insolvency from demanded repayment—but it also suggests the business may have difficulty obtaining credit.
Shareholders' Funds vs. P&L Reserve
| Component | 2026 | 2025 |
|---|---|---|
| Share Capital | £100 | £100 |
| Revaluation Reserve | £12,845 | £12,845 |
| P&L Reserve | £80,369 | £167,006 |
| Total Shareholders' Funds | £93,314 | £179,951 |
Interpretation: The P&L reserve has fallen by £86,637 in a single year, confirming that trading losses are consuming accumulated profits. The revaluation reserve remains static at £12,845, suggesting a past revaluation of an asset (likely the computer equipment or an investment property interest) that has not been adjusted.
3. Diagnosis
Primary Condition: Chronic Operational Deficit Disorder
Red Raven Limited is suffering from a sustained inability to generate sufficient revenue to cover its operating costs. This is not a sudden crisis but a long-term, progressive condition that has persisted for at least nine consecutive years.
Key Findings:
1. Revenue Insufficiency: The company's IT services activities (SIC 62090) are not generating enough income to sustain the business. With only 2 employees (both directors), this appears to be a micro-enterprise where director-remuneration likely represents the largest cost—yet revenue cannot even cover this modest expense.
2. Asset Liquidation Phase: The 2023 cash spike, combined with the corresponding drop in total assets from £433,295 (2022) to £360,039 (2023), strongly suggests the company sold approximately £300,000 of investments or other fixed assets to bolster cash. This is a classic symptom of a business consuming its own capital to survive—a patient burning muscle tissue when food is scarce.
3. Minimal Trading Activity: With only £1 in trade creditors (2026), the business appears to have virtually no supplier relationships or purchasing activity. Combined with the tiny fixed asset base (computer equipment at £903 net book value), this paints a picture of a business that may be largely dormant or operating at minimal capacity.
4. Director Dependency: Mr. Simon Peter Hollins holds over 75% control. The business is entirely dependent on two director-employees with no external investment, no debt financing, and apparently diminishing client relationships.
5. Accelerating Decline: The rate of annual loss has increased from approximately £12,000 (2018) to £87,000-£95,000 (2025-2026), suggesting the underlying business condition is worsening, not stabilizing.
4. Prognosis
Short-term (0-12 months): Guarded
The company has approximately £93,592 in cash and negligible liabilities, so there is no immediate risk of insolvency. However, at the current burn rate, cash will be exhausted within 12-13 months.
Medium-term (1-3 years): Poor
Without a significant change in trading performance, the company will deplete its remaining reserves and become insolvent. The revaluation reserve of £12,845 may not be realisable, and once cash falls below operational needs, the business will cease to function.
Long-term (3+ years): Critical unless treated
The trajectory is clearly unsustainable. Continued losses at this rate will see the company's net assets approach zero within approximately 12 months, at which point directors must consider whether the company can continue as a going concern.
5. Recommendations
Immediate Actions (Within 30 Days)
-
Conduct a Revenue Health Review: Examine whether the current business model is viable. Are there active clients? What is the monthly revenue run rate? If revenue has effectively ceased, the directors must honestly assess whether the business can be revived.
-
Prepare a Cash Flow Forecast: Map out expected cash inflows and outflows for the next 12 months. At approximately £86,000 annual burn, the company needs either £86,000 in new revenue or must reduce costs by a comparable amount.
-
Director Remuneration Assessment: Given the business is loss-making, review whether director drawings/salaries are appropriate. The P&L reserve decline suggests remuneration significantly exceeds revenue.
Short-term Actions (1-6 Months)
-
Strategic Pivot or Wind-Down Decision: The directors face a clear choice: - Revive: Invest in business development to generate sufficient revenue to at least break even - Reduce: Minimise all non-essential expenditure and potentially operate the business at a much lower cost base - Close: Voluntarily strike off the company while it still has assets to distribute to shareholders (currently £93,314 in net assets)
-
Consider Members' Voluntary Liquidation (MVL): If the business is no longer viable, an MVL would allow the £93,314 in net assets to be distributed to shareholders as capital (potentially attracting lower tax rates than income distributions) before the value is entirely consumed by losses.
-
Review the Revaluation Reserve: The £12,845 revaluation reserve should be assessed. If the underlying asset has decreased in value, this should be written down to reflect reality and provide a more accurate picture of the company's position.
Ongoing Monitoring
-
Monthly Financial Check-ups: Implement monthly management accounts to track revenue, costs, and cash position. A business this size should not discover its financial position only once a year.
-
Going Concern Assessment: As net assets approach zero, the directors have a legal duty to assess whether the company can continue as a going concern. If not, they must consider formal insolvency procedures to avoid wrongful trading.
Summary Table
| Metric | Status | Trend |
|---|---|---|
| Net Assets | Declining rapidly | ↓↓↓ |
| Cash Position | Depleting at ~£86k/year | ↓↓↓ |
| Liabilities | Minimal | ✓ (Healthy) |
| Current Ratio | Extremely strong | ✓ (But misleading) |
| Profitability | Persistent losses | ↓↓↓ |
| Going Concern Risk | Elevated | ↓↓ |
| Cash Runway | ~12 months | ↓↓ |